-
Bazedoxifene Workflows for Osteoporosis Research
2026-08-11
Build more informative estrogen receptor assays with Bazedoxifene by pairing receptor pharmacology, estrogen-challenge controls, and bone-relevant endpoints. This workflow connects cell-based mechanism studies with ovariectomized-animal models while addressing solubility, vehicle, dosing, and interpretation challenges.
-
Cepharanthine in Organoid Apoptosis Research
2026-08-10
Cepharanthine supports a three-tier endometriosis workflow spanning stromal cells, patient-derived organoids, and a peritoneal mouse model. This guide explains formulation, assay design, translational use cases, and troubleshooting while separating published findings from practical starting conditions.
-
Protease Inhibitor Cocktail for Lipid Droplet Assays
2026-08-09
Protect DFCP1–ATGL complexes and other labile proteins during lipid droplet extraction, Western blotting, Co-IP, and fractionation. This water-soluble 100X formulation offers broad inhibitor coverage, while its EDTA component requires deliberate validation for metal-dependent assays and purification.
-
Cepharanthine Workflow for Endometriosis Models
2026-08-08
Cepharanthine, a biscoclaurine alkaloid, supports a translational workflow spanning stromal-cell assays, patient-derived endometrial organoids, and murine lesion models. This guide converts apoptosis, DNA-damage, and cell-cycle findings into practical formulation, assay-design, and troubleshooting decisions.
-
Ibrexafungerp Activity Against Resistant Candida auris
2026-08-07
A 2021 study evaluated Ibrexafungerp, also known as MK 3118, against fluconazole-resistant Candida auris using broth microdilution and a delayed-treatment murine model of invasive candidiasis. The compound retained consistent in vitro activity and improved outcomes in infected mice at higher oral doses, supporting further investigation of an orally administered glucan-synthase inhibitor for difficult Candida infections.
-
Decoding Acidic Protein Function: Native PAGE Kit for PI ≤ 7
2026-08-07
Explore how the Basic Protein Native PAGE Gel Preparation and Electrophoresis Kit empowers researchers to resolve, identify, and analyze acidic proteins in their native forms. This in-depth article reveals scientific advances, assay strategy, and unique applications not covered elsewhere.
-
Revolutionizing Cisplatin Research: Mechanisms, Resistance,
2026-08-06
This thought-leadership article reframes the strategic use of Cisplatin (CDDP) in translational cancer research, with a mechanistic deep dive into DNA crosslinking, apoptosis, and the latest breakthroughs in chemoresistance. We integrate cutting-edge findings on TNFAIP2-mediated resistance and KEAP1/NRF2 signaling, paired with actionable guidance for optimizing apoptosis assays and xenograft models. Anchored in APExBIO’s product intelligence, this piece sets a new benchmark for leveraging CDDP in advanced experimental workflows.
-
Cepharanthine: Mechanistic Leverage for Translational Diseas
2026-08-06
Cepharanthine, a biscoclaurine alkaloid, is redefining translational research by uniting apoptosis induction, immunomodulation, and disease modeling for both cancer and endometriosis. This thought-leadership article presents mechanistic insights, recent experimental advances, and actionable guidance for researchers seeking to maximize Cepharanthine’s impact from in vitro organoids to in vivo systems. Drawing upon pivotal new findings, validated workflows, and the competitive landscape, we position APExBIO’s high-purity Cepharanthine as a cornerstone for robust, reproducible translational workflows while offering strategic foresight for the field.
-
SIRT1/2 Inhibitor IV (cambinol): Applied Workflows in CNS an
2026-08-05
SIRT1/2 Inhibitor IV (cambinol) is redefining metabolic-epigenetic research by enabling precise modulation of SIRT1/2-driven pathways in both central nervous system injury and oncology models. Leveraging new mechanistic findings, researchers can now dissect astrocyte polarization and tumor suppression with robust, evidence-backed protocols.
-
GSK3 Inhibition as a Host-Directed Strategy for Tuberculosis
2026-08-05
The referenced iScience study demonstrates that inhibiting glycogen synthase kinase 3 (GSK3) in human macrophages restricts the intracellular growth of Mycobacterium tuberculosis, offering a host-directed alternative to traditional antibiotic therapy. These findings highlight a promising direction for controlling tuberculosis, particularly in the context of multi-drug resistant strains, by targeting host pathways rather than the pathogen directly.
-
O-propargyl-puromycin: Precision Protein Synthesis Measureme
2026-08-04
O-propargyl-puromycin (OPP) enables direct, sensitive detection of nascent protein synthesis in live cells, offering a distinct edge for immunology and proteomics workflows. Its click-chemistry compatibility streamlines experimental design and troubleshooting, making it indispensable for dissecting mitochondrial and translational control in antibody-producing B cells.
-
Bazedoxifene: Selective Estrogen Receptor Modulator in Resea
2026-08-04
Bazedoxifene offers researchers a powerful, selective tool for dissecting estrogen receptor signaling, osteoporosis models, and emerging cancer pathways. With robust tissue selectivity and a newly discovered role in IL-6/GP130 inhibition, it enables nuanced experimental design and translational insight across endocrine and oncology research.
-
(R,S)-Anatabine: Applied Workflows for Alzheimer’s Disease M
2026-08-03
(R,S)-Anatabine enables targeted soluble Aβ reduction and inflammation control in Alzheimer’s disease research, with proven performance in both in vitro and in vivo models. This guide delivers protocol enhancements, troubleshooting tactics, and insights for maximizing translational impact using APExBIO’s high-purity compound.
-
Trim71-Ago2-let-7 Axis Regulates Pluripotency in mESCs
2026-08-03
Liu et al. (2021) elucidate a cytoplasmic mechanism in mouse embryonic stem cells whereby Trim71 maintains pluripotency by repressing Ago2 mRNA translation, thereby suppressing let-7 microRNA maturation. This work advances understanding of post-transcriptional pluripotency regulation and informs stem cell differentiation protocols.
-
Scenario-Driven Insights: YM-155 Hydrochloride in Cancer Ass
2026-08-02
This article delivers a scenario-based, evidence-driven guide for leveraging YM-155 hydrochloride (SKU A3947) in cell viability and apoptosis research. Drawing on both validated protocols and peer-reviewed findings, it addresses common laboratory challenges and highlights how APExBIO's YM-155 hydrochloride enhances experimental reproducibility, sensitivity, and workflow reliability.